Gennex Laboratories News

Gennex Labs Q3FY26 Net Profit Rises 18.3% YoY

Gennex Laboratories reported consolidated net profit of ₹599.22 lakhs for Q3FY26, up 18.3% YoY. Revenue from operations grew 7.1% to ₹4,036.64 lakhs with strong performance in bulk drugs.

Gennex Laboratories Reports Strong Q1 Growth with 20% Revenue Jump and 176% Profit Surge

Gennex Laboratories reported standalone revenue of Rs 2,564 lacs for the quarter ended June 30, 2025, up from Rs 2,133.40 lacs in the same quarter last year. Net profit increased significantly to Rs 414.95 lacs compared to Rs 416.60 lacs in the previous year quarter. On a consolidated basis, revenue reached Rs 3,417.75 lacs versus Rs 2,832.18 lacs in the prior year quarter, while net profit was Rs 501.64 lacs compared to Rs 465.84 lacs. The company's paid-up equity share capital increased to Rs 2,314.48 lacs from Rs 2,274.48 lacs. Basic earnings per share stood at Rs 0.179 for standalone and Rs 0.217 for consolidated results. The board meeting was held on August 14, 2025, where directors approved the unaudited financial statements along with limited review reports from statutory auditors.